Healthcare News and Headlines
Healthcare News and Headlines
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
London Health Sciences Centre surgeons performed the world’s first pituitary tumor removal using a Hyperfine Swoop portable MRI. The low‑field 0.064 T scanner was wheeled into the operating room, delivering real‑time images of the gland and surrounding vessels. Immediate intra‑operative feedback allowed the team to identify and excise residual tumor tissue before closing. Dr. Neil Duggal hailed the approach as a game‑changer for complex neurosurgery because it eliminates the need to transport patients to a conventional scanner.
The University of Toronto and the Indian Institute of Science announced a joint centre of excellence to develop AI‑driven predictive healthcare tools. The partnership, unveiled in Mumbai, is part of a broader Canada‑India Talent and Innovation Strategy and includes a...
Veterinary fees in the UK have surged 63% since 2016, outpacing inflation, as corporate groups now own 60% of practices. The Competition and Markets Authority is poised to release a report demanding price transparency and easier online access to cheaper...
Kindly, a Canadian‑founded tech firm, has launched a national care‑navigation platform that blends AI with licensed experts to support families caring for aging loved ones. Backed by TD Innovation Partners, Felix Health and Halo Health, the service is being offered...
Ontario hospitals face a looming financial crisis as operating costs climb 6% yearly while government funding rises only 4%, creating a $1 billion structural deficit. Hospitals have exhausted reserve funds and identified $500 million in cost‑saving opportunities, the limit before patient care...
Ontario’s Primary Care Action Team aims to attach every resident to a primary care provider, but OHTs face a digital infrastructure gap. An executive briefing on March 31 will showcase modular, HALO‑aligned solutions that streamline access through single sign‑on, AI navigation,...
MEDITECH announced at HIMSS26 the expansion of its Expanse AI portfolio with native ambient intelligence integrated into the Expanse Now mobile app for physicians and Expanse Point of Care app for nurses. The solution captures real‑time conversations, automatically generates visit...
CorMedix reported Q4 2025 revenue of $128.6 million, propelled by DEFENCATH ($91.2 M) and the first full‑quarter contribution from the Melinta acquisition ($37.4 M). Full‑year pro forma revenue reached $401.3 million, matching prior guidance, with DEFENCATH net sales totaling $258.8 million. Adjusted EBITDA for the...
Guardian Pharmacy Services reported a strong Q4 2025, serving over 205,000 residents and generating $397.6 million in revenue, a 17% increase year‑over‑year with 12% organic growth. Adjusted EBITDA jumped 53% to $39.5 million, lifting the quarterly margin to 9.9% and prompting an...
Veru Inc. reported a $23.4 million public offering that lifted cash and working capital to $33 million and $29.7 million respectively, while narrowing its quarterly net loss to $5.3 million ($0.26 per share). The company received FDA feedback confirming two regulatory pathways for its...
Vanda Pharmaceuticals reported 2025 revenue of $216.1 million, up 9% year‑over‑year, driven primarily by Fanapt’s 24% sales increase and a successful bipolar launch. The company secured FDA approval for tradipitant (Nirius) to prevent motion‑sickness vomiting, with a commercial rollout slated for...
Elutia Inc. reported a 49% sequential revenue surge for its LU Pro bio‑envelope, driven by new hospital contracts and seven national GPO agreements, pushing the product toward a $20 million run‑rate by year‑end. The company settled the bulk of legacy litigation, resolving...
Australian universities can now apply for a share of 50 new government‑funded medical placements, with applications opening Tuesday and closing on April 7. The round, backed by more than $5.7 million, will roll out in 2028 and targets an expansion of general...
Singapore is building a next‑generation, AI‑enabled Eastern General Hospital, scheduled to open around 2029. The smart hospital roadmap integrates digital platforms, AI, robotics, wearables, and real‑time location systems to enhance clinical and operational efficiency. Telehealth and generative AI tools aim...
The FDA granted approval for leucovorin calcium tablets to treat a rare genetic disorder that impairs folate transport to the brain. Unlike typical approvals, the agency relied primarily on a handful of patient case reports rather than a sponsor‑run clinical...
The Medicare Shared Savings Program (MSSP) now includes 476 ACOs, aiming to cut costs and boost quality through value‑based care. Atlantic Health partnered with Innovaccer to embed AI‑driven clinical intelligence across more than 120 EHR systems. The collaboration generated $15 million...
The article outlines the wide range of supplemental benefits available through Federal Employees Health Benefits (FEHB), FEDVIP, and Medicare Advantage plans, including wellness incentives, gym discounts, and Smart Shopper credits. It lists specific reward amounts for popular carriers in the...
Missouri lawmakers are advancing a bill that would increase penalties for nursing‑home abuse to a Class E felony and require facilities to carry at least $1 million in liability insurance. The legislation also mandates the Department of Health and Senior Services to...
Stryker Medical President Jessica Mathieson emphasized a simple career mantra: talk less, listen more, and seek mentors who can spark ideas. Drawing on 17 years at Stryker, she rose from account manager to president, highlighting the role of mentorship and...
Silicon Valley’s newest wave of health‑tech startups is targeting America’s $5 trillion, fragmented medical system. Patients increasingly skip or delay care because of cost, with roughly one‑third reporting financial barriers. These disrupters are leveraging artificial intelligence to streamline diagnosis, pricing transparency,...
The FDA’s artificial‑intelligence advisor announced a shift toward evaluating AI‑driven health technologies on a case‑by‑case basis, focusing on each tool’s specific function rather than applying a one‑size‑fits‑all rule set. This risk‑based approach will tailor regulatory requirements to the actual clinical...
A recent study in Emergency Radiology shows that standardized reporting templates significantly speed up on‑call radiology residents’ preliminary interpretations of after‑hours spinal MRIs. Average turnaround time fell from 54 to 47 minutes, and the incidence of delays exceeding 75 minutes...
HarmonyCares executives are upbeat about the upcoming LEAD alternative payment model, slated to begin in 2027 and designed for small, rural and independent primary‑care practices serving high‑needs patients. They highlight LEAD’s improved benchmarking and risk‑adjustment methods, which address shortcomings they...
Global health systems have reached roughly 65% of the key AI readiness indicators, according to HIMSS chief scientific research officer Anne Snowdon. Governance frameworks and workforce development programs have improved, yet substantial gaps remain in data infrastructure, interoperability, and change‑management...
Teladoc Health’s CEO Chuck Divita reported that the company’s BetterHelp mental‑health platform is gaining traction with insurer‑covered members after the $30 million acquisition of UpLift Technologies. UpLift’s network of 1,500 providers generated $13 million in revenue last year, putting the insurance‑covered stream...
The FDA approved 18 biosimilars in 2025, spanning six therapeutic areas and marking a surge in interchangeable designations to over 20. A wave of denosumab biosimilars and first‑in‑kind interchangeable products such as Poherdy® and Omlyclo® highlighted market diversification. BPCIA litigation...
Public Citizen announced it will encourage compulsory licensing of generic drugs if Pfizer follows through on its January threat to withhold medicines from France unless the country raises drug prices. The consumer group’s stance turns a pricing dispute into a...
Researchers at the University of Toronto have engineered synthetic long non‑coding RNA (lncRNA) molecules that can dampen inflammatory responses. The study, led by PhD student Janice Pang and biologist Omar Khan, demonstrates that these engineered lncRNAs reduce cytokine release in...
Ochsner Health and the MD Anderson Cancer Center have launched a joint precision radiation oncology program in New Orleans, marking the first Southern U.S. facility to offer MR‑guided adaptive radiotherapy. The center leverages AI‑driven treatment planning and real‑time imaging to...
Cook Medical has designated Indiana University as one of its inaugural Interventional MRI (iMRI) Centers of Excellence, part of a five‑year collaboration with the IU Launch Accelerator for Biosciences. The initiative blends device engineering, imaging science, and clinical research to...
New Jersey has launched a $150 million maternal‑health fund aimed at high‑risk pregnancies and expanding community health centers across the state. The initiative pairs public dollars with private investors to build regional perinatal care networks that leverage data analytics and tele‑health....
Protara Therapeutics reported a Q4 2025 loss of $0.37 per share, an improvement from the $0.48 loss a year earlier. The narrowing loss reflects higher clinical development spending as the company advances its lead cell‑therapy candidate, TARA-002, into Phase II...
A new JAMA Ophthalmology study of 184,504 eyes shows glaucoma treatment decisions rise continuously with intra‑ocular pressure (IOP) rather than at a hard 22 mm Hg cutoff. Researchers examined over 1.8 million visits across seven academic centers and found odds of initiating therapy...
Quintessa Haile, a home care aide at Help at Home, was named a 2025 Frontline Honors Award winner by Home Health Care News. In a recent interview she explained that personal caregiving for her mother sparked her commitment to the...
Apyx Medical Corporation reported its fourth‑quarter FY25 results, posting a loss of $0.03 per share on $19.2 million of revenue. Revenue surged 34.8% year‑over‑year, propelled by the Advanced Energy and Original Equipment Manufacturing segments. The loss narrowed from $0.06 per share...
Researchers published a comparative study in Pediatric Research showing that procalcitonin (PCT) rises within 6‑12 hours of infection in very low birth weight infants, while C‑reactive protein (CRP) peaks later at 24‑48 hours. The data reveal that PCT offers higher...
A mock‑trial study published in Nature Health examined how jurors assign liability when radiologists use AI in interpreting CT scans. When AI flagged a brain bleed and the radiologist reviewed the image only once, 75% of jurors held the radiologist...
The study of over 5 million first‑time Medicare Advantage (MA) enrollees from 2012‑2022 shows a marked rise in demographic and socioeconomic diversity, with dual‑eligible beneficiaries climbing from 13% to 23% and Black enrollees from 12.7% to 18.3%. Clinical complexity also increased...
A ten‑year audit at Moorfields Eye Hospital revealed an intraoperative intraocular lens (IOL) complication rate of just 0.11%, with 193 events out of 176,663 cataract surgeries. The most frequent issue, unplanned IOL exchange, accounted for 69% of complications and was...
London’s Hackney and Camden boroughs will host the capital’s first drug‑checking services, operated by harm‑reduction charity The Loop. The clinics are fully funded by the councils and backed by the Metropolitan Police, offering free, confidential testing, rapid substance analysis, and...
The Nebraska Health Care Foundation has funded a new documentary series that follows hospice clinicians across seven care settings in Nebraska, aiming to demystify hospice, palliative and long‑term care. By showcasing real‑world stories, the series seeks to attract and retain...
UK's junk‑food advertising ban, introduced Jan 5, will affect only about 1% of the £2.4 bn annual food‑drink ad spend after industry‑driven loopholes. Nesta's analysis shows coverage dropping from £190 m (8%) to £20 m (1%) as brands shift spend to outdoor and owned...
The RENOVATE‑COMPLEX‑PCI trial’s 5‑year follow‑up confirms that intravascular imaging guidance markedly lowers target‑lesion failure and cardiac death compared with angiography alone, especially in chronic total occlusions and long diffuse lesions. Across 1,639 patients, target‑lesion failure occurred in 10.5% of the...
Stanford Medicine’s inaugural Consumer Health Summit attracted over 400 participants, positioning the university as a nexus for consumer‑health innovation. Attendees—including founders, investors, clinicians, and academics—explored how to turn abundant biometric data into actionable behavior change, earn regulatory trust, and build...
Lundbeck chief executive Charl van Zyl warned that Europe’s fragmented drug‑pricing regime threatens biotech sustainability and patient access. He cited recent remarks by HHS Secretary Robert F. Kennedy Jr. suggesting Europeans already pay higher prices than Americans. Van Zyl called...
The FDA has cleared Pylarify TruVu, a reformulated version of Lantheus’ PSMA‑targeting radiopharmaceutical piflufolastat F‑18. The new formulation improves stability at higher radioactive concentrations, enabling larger batch production and broader distribution. Lantheus plans a Q4 2026 commercial launch with a rolling geographic...
The American Hospital Association’s Foster G. McGaw Prize spotlights hospitals that extend care beyond their walls through community partnerships. Recent finalists introduced adaptive‑sports programs for disabled children, teen clinical rotations, child‑led playground design, and student navigators for food‑insecure patients. CEOs...
Blair Health, a virtual women’s‑health platform, is tackling a $15 billion annual cost gap where female employees spend 18% more out‑of‑pocket than men. By offering specialist‑level care for a flat $200 per employee per year, the startup claims it can redirect...
A longitudinal study of 46 million outpatient encounters shows telemedicine use has settled at roughly 5‑6% of visits, far above pre‑pandemic levels. Utilization is higher among younger, female, portal‑savvy, and returning patients, while older adults, men, and new patients are less...
Johnson & Johnson has filed a Type II variation with the European Medicines Agency to add teclistamab, a bispecific T‑cell‑redirecting antibody, as a second‑line monotherapy for relapsed/refractory multiple myeloma. The Phase III MajesTEC‑9 trial, enrolling 614 patients, demonstrated a 71 % reduction in...
